EGFR and colorectal carcinoma: Our results showed 13 potential targets of biochanin A; the molecular interaction network analysis using Cytoscape further highlighted the involvement of six core targets of biochanin A, EGFR, CCND1, IL2, IL1A, IL6R, and PPARG, for the treatment of CRC/COVID-19 (Figure 2b).